Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2025 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
November 12, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
July 10, 2024 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
May 28, 2024 08:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics to Participate in Upcoming Investor Conferences
November 09, 2023 20:07 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces Pricing of Initial Public Offering

CARGO Therapeutics Announce Pricing of IPO
March 02, 2021 09:00 ET | Source: Sorrento Therapeutics, Inc.

Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple Malignancies

Internally developed fully human anti-CD47 antibody (STI-6643) cleared for basket trial;No complicated titration or priming dose of the antibody is required to reduce toxicity;This study will be...